nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—Alkylating Activity—Thiotepa—breast cancer	0.173	0.333	CiPCiCtD
Trabectedin—Alkylating Activity—Chlorambucil—breast cancer	0.173	0.333	CiPCiCtD
Trabectedin—Alkylating Activity—Melphalan—breast cancer	0.173	0.333	CiPCiCtD
Trabectedin—SRC—breast cancer	0.104	0.512	CbGaD
Trabectedin—PTGS1—breast cancer	0.0436	0.215	CbGaD
Trabectedin—CYP2D6—breast cancer	0.0297	0.147	CbGaD
Trabectedin—CYP3A4—breast cancer	0.0255	0.126	CbGaD
Trabectedin—CYP2C9—Anastrozole—breast cancer	0.0116	0.0773	CbGbCtD
Trabectedin—CYP2C19—Lapatinib—breast cancer	0.00934	0.062	CbGbCtD
Trabectedin—CYP3A4—Exemestane—breast cancer	0.00893	0.0593	CbGbCtD
Trabectedin—CYP2C9—Idarubicin—breast cancer	0.00882	0.0586	CbGbCtD
Trabectedin—CYP2D6—Idarubicin—breast cancer	0.00806	0.0536	CbGbCtD
Trabectedin—CYP3A4—Letrozole—breast cancer	0.00759	0.0504	CbGbCtD
Trabectedin—CYP2E1—Tamoxifen—breast cancer	0.00746	0.0496	CbGbCtD
Trabectedin—CYP2E1—Mitoxantrone—breast cancer	0.00728	0.0483	CbGbCtD
Trabectedin—CYP3A4—Anastrozole—breast cancer	0.00677	0.045	CbGbCtD
Trabectedin—CYP3A4—Toremifene—breast cancer	0.00619	0.0411	CbGbCtD
Trabectedin—CYP3A4—Fulvestrant—breast cancer	0.00575	0.0382	CbGbCtD
Trabectedin—CYP3A4—Thiotepa—breast cancer	0.00513	0.0341	CbGbCtD
Trabectedin—CYP2C9—Capecitabine—breast cancer	0.00483	0.0321	CbGbCtD
Trabectedin—CYP3A4—Ixabepilone—breast cancer	0.00469	0.0312	CbGbCtD
Trabectedin—CYP2C19—Tamoxifen—breast cancer	0.00468	0.0311	CbGbCtD
Trabectedin—CYP3A4—Lapatinib—breast cancer	0.00451	0.03	CbGbCtD
Trabectedin—CYP2D6—Vinorelbine—breast cancer	0.00394	0.0262	CbGbCtD
Trabectedin—CYP2C9—Tamoxifen—breast cancer	0.00389	0.0258	CbGbCtD
Trabectedin—CYP2D6—Tamoxifen—breast cancer	0.00356	0.0236	CbGbCtD
Trabectedin—CYP3A4—Raloxifene—breast cancer	0.00342	0.0227	CbGbCtD
Trabectedin—CYP2C9—Paclitaxel—breast cancer	0.00303	0.0201	CbGbCtD
Trabectedin—CYP2C9—Fluorouracil—breast cancer	0.00287	0.019	CbGbCtD
Trabectedin—CYP3A4—Vinorelbine—breast cancer	0.0025	0.0166	CbGbCtD
Trabectedin—CYP2D6—Vinblastine—breast cancer	0.00243	0.0161	CbGbCtD
Trabectedin—CYP3A4—Tamoxifen—breast cancer	0.00226	0.015	CbGbCtD
Trabectedin—CYP3A4—Mitoxantrone—breast cancer	0.0022	0.0146	CbGbCtD
Trabectedin—CYP3A4—Paclitaxel—breast cancer	0.00176	0.0117	CbGbCtD
Trabectedin—CYP3A4—Irinotecan—breast cancer	0.00174	0.0115	CbGbCtD
Trabectedin—CYP3A4—Vinblastine—breast cancer	0.00154	0.0103	CbGbCtD
Trabectedin—CYP2D6—Doxorubicin—breast cancer	0.00149	0.00991	CbGbCtD
Trabectedin—CYP3A4—Docetaxel—breast cancer	0.00127	0.00845	CbGbCtD
Trabectedin—CYP3A4—Doxorubicin—breast cancer	0.000948	0.0063	CbGbCtD
Trabectedin—SRC—embryo—breast cancer	0.000224	0.085	CbGeAlD
Trabectedin—SRC—epithelium—breast cancer	0.000183	0.0694	CbGeAlD
Trabectedin—SRC—skin of body—breast cancer	0.000174	0.066	CbGeAlD
Trabectedin—SRC—adipose tissue—breast cancer	0.000148	0.0561	CbGeAlD
Trabectedin—SRC—female reproductive system—breast cancer	0.000136	0.0516	CbGeAlD
Trabectedin—CYP2C9—mammary gland—breast cancer	0.000134	0.0509	CbGeAlD
Trabectedin—SRC—adrenal gland—breast cancer	0.000132	0.0503	CbGeAlD
Trabectedin—SRC—female gonad—breast cancer	0.000123	0.0469	CbGeAlD
Trabectedin—SRC—endocrine gland—breast cancer	0.000115	0.0436	CbGeAlD
Trabectedin—PTGS1—nipple—breast cancer	0.000101	0.0385	CbGeAlD
Trabectedin—SRC—lymph node—breast cancer	7.94e-05	0.0302	CbGeAlD
Trabectedin—PTGS1—epithelium—breast cancer	6.82e-05	0.0259	CbGeAlD
Trabectedin—PTGS1—skin of body—breast cancer	6.49e-05	0.0246	CbGeAlD
Trabectedin—PTGS1—endometrium—breast cancer	6.11e-05	0.0232	CbGeAlD
Trabectedin—CYP2C19—endocrine gland—breast cancer	6.06e-05	0.023	CbGeAlD
Trabectedin—PTGS1—uterus—breast cancer	5.63e-05	0.0214	CbGeAlD
Trabectedin—CYP2C9—female reproductive system—breast cancer	5.55e-05	0.0211	CbGeAlD
Trabectedin—PTGS1—pituitary gland—breast cancer	5.53e-05	0.021	CbGeAlD
Trabectedin—PTGS1—adipose tissue—breast cancer	5.51e-05	0.0209	CbGeAlD
Trabectedin—CYP2E1—female reproductive system—breast cancer	5.26e-05	0.02	CbGeAlD
Trabectedin—CYP2E1—adrenal gland—breast cancer	5.13e-05	0.0195	CbGeAlD
Trabectedin—PTGS1—female reproductive system—breast cancer	5.07e-05	0.0192	CbGeAlD
Trabectedin—PTGS1—adrenal gland—breast cancer	4.94e-05	0.0188	CbGeAlD
Trabectedin—CYP2C9—endocrine gland—breast cancer	4.7e-05	0.0178	CbGeAlD
Trabectedin—PTGS1—female gonad—breast cancer	4.61e-05	0.0175	CbGeAlD
Trabectedin—CYP2E1—endocrine gland—breast cancer	4.45e-05	0.0169	CbGeAlD
Trabectedin—PTGS1—endocrine gland—breast cancer	4.29e-05	0.0163	CbGeAlD
Trabectedin—CYP3A4—female reproductive system—breast cancer	4.23e-05	0.0161	CbGeAlD
Trabectedin—CYP2D6—female reproductive system—breast cancer	4.16e-05	0.0158	CbGeAlD
Trabectedin—CYP2D6—female gonad—breast cancer	3.79e-05	0.0144	CbGeAlD
Trabectedin—CYP3A4—endocrine gland—breast cancer	3.58e-05	0.0136	CbGeAlD
Trabectedin—CYP2D6—endocrine gland—breast cancer	3.52e-05	0.0134	CbGeAlD
Trabectedin—PTGS1—lymph node—breast cancer	2.96e-05	0.0113	CbGeAlD
Trabectedin—Fatigue—Paclitaxel—breast cancer	1.86e-05	0.000238	CcSEcCtD
Trabectedin—Haemorrhage—Methotrexate—breast cancer	1.85e-05	0.000237	CcSEcCtD
Trabectedin—Asthenia—Gemcitabine—breast cancer	1.85e-05	0.000236	CcSEcCtD
Trabectedin—Myalgia—Capecitabine—breast cancer	1.84e-05	0.000236	CcSEcCtD
Trabectedin—Arthralgia—Capecitabine—breast cancer	1.84e-05	0.000236	CcSEcCtD
Trabectedin—Constipation—Paclitaxel—breast cancer	1.84e-05	0.000236	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	1.83e-05	0.000234	CcSEcCtD
Trabectedin—Hepatobiliary disease—Epirubicin—breast cancer	1.83e-05	0.000234	CcSEcCtD
Trabectedin—Oedema—Docetaxel—breast cancer	1.83e-05	0.000234	CcSEcCtD
Trabectedin—Nausea—Thiotepa—breast cancer	1.82e-05	0.000233	CcSEcCtD
Trabectedin—Infection—Docetaxel—breast cancer	1.81e-05	0.000232	CcSEcCtD
Trabectedin—Weight decreased—Doxorubicin—breast cancer	1.81e-05	0.000232	CcSEcCtD
Trabectedin—Diarrhoea—Irinotecan—breast cancer	1.81e-05	0.000231	CcSEcCtD
Trabectedin—Diarrhoea—Mitoxantrone—breast cancer	1.81e-05	0.000231	CcSEcCtD
Trabectedin—Agranulocytosis—Epirubicin—breast cancer	1.8e-05	0.000231	CcSEcCtD
Trabectedin—Shock—Docetaxel—breast cancer	1.8e-05	0.00023	CcSEcCtD
Trabectedin—Nervous system disorder—Docetaxel—breast cancer	1.79e-05	0.000229	CcSEcCtD
Trabectedin—Thrombocytopenia—Docetaxel—breast cancer	1.79e-05	0.000229	CcSEcCtD
Trabectedin—Infestation NOS—Doxorubicin—breast cancer	1.79e-05	0.000229	CcSEcCtD
Trabectedin—Infestation—Doxorubicin—breast cancer	1.79e-05	0.000229	CcSEcCtD
Trabectedin—Skin disorder—Docetaxel—breast cancer	1.77e-05	0.000227	CcSEcCtD
Trabectedin—Oedema—Capecitabine—breast cancer	1.77e-05	0.000226	CcSEcCtD
Trabectedin—Gastrointestinal pain—Paclitaxel—breast cancer	1.76e-05	0.000225	CcSEcCtD
Trabectedin—Diarrhoea—Gemcitabine—breast cancer	1.76e-05	0.000225	CcSEcCtD
Trabectedin—Infection—Capecitabine—breast cancer	1.76e-05	0.000225	CcSEcCtD
Trabectedin—Dizziness—Irinotecan—breast cancer	1.75e-05	0.000224	CcSEcCtD
Trabectedin—Haemoglobin—Epirubicin—breast cancer	1.74e-05	0.000223	CcSEcCtD
Trabectedin—Jaundice—Doxorubicin—breast cancer	1.74e-05	0.000223	CcSEcCtD
Trabectedin—Stomatitis—Doxorubicin—breast cancer	1.74e-05	0.000223	CcSEcCtD
Trabectedin—Anorexia—Docetaxel—breast cancer	1.74e-05	0.000223	CcSEcCtD
Trabectedin—Shock—Capecitabine—breast cancer	1.74e-05	0.000223	CcSEcCtD
Trabectedin—Nervous system disorder—Capecitabine—breast cancer	1.73e-05	0.000222	CcSEcCtD
Trabectedin—Haemorrhage—Epirubicin—breast cancer	1.73e-05	0.000222	CcSEcCtD
Trabectedin—Diarrhoea—Fluorouracil—breast cancer	1.73e-05	0.000222	CcSEcCtD
Trabectedin—Thrombocytopenia—Capecitabine—breast cancer	1.73e-05	0.000222	CcSEcCtD
Trabectedin—Skin disorder—Capecitabine—breast cancer	1.72e-05	0.00022	CcSEcCtD
Trabectedin—Oedema peripheral—Epirubicin—breast cancer	1.71e-05	0.000219	CcSEcCtD
Trabectedin—Hypotension—Docetaxel—breast cancer	1.71e-05	0.000218	CcSEcCtD
Trabectedin—Connective tissue disorder—Epirubicin—breast cancer	1.7e-05	0.000218	CcSEcCtD
Trabectedin—Abdominal pain—Paclitaxel—breast cancer	1.7e-05	0.000218	CcSEcCtD
Trabectedin—Body temperature increased—Paclitaxel—breast cancer	1.7e-05	0.000218	CcSEcCtD
Trabectedin—Hepatobiliary disease—Doxorubicin—breast cancer	1.69e-05	0.000216	CcSEcCtD
Trabectedin—Anorexia—Capecitabine—breast cancer	1.68e-05	0.000216	CcSEcCtD
Trabectedin—Angiopathy—Methotrexate—breast cancer	1.68e-05	0.000215	CcSEcCtD
Trabectedin—Vomiting—Mitoxantrone—breast cancer	1.68e-05	0.000215	CcSEcCtD
Trabectedin—Vomiting—Irinotecan—breast cancer	1.68e-05	0.000215	CcSEcCtD
Trabectedin—Dizziness—Fluorouracil—breast cancer	1.67e-05	0.000214	CcSEcCtD
Trabectedin—Mediastinal disorder—Methotrexate—breast cancer	1.67e-05	0.000214	CcSEcCtD
Trabectedin—Agranulocytosis—Doxorubicin—breast cancer	1.67e-05	0.000213	CcSEcCtD
Trabectedin—Rash—Irinotecan—breast cancer	1.67e-05	0.000213	CcSEcCtD
Trabectedin—Rash—Mitoxantrone—breast cancer	1.67e-05	0.000213	CcSEcCtD
Trabectedin—Dermatitis—Mitoxantrone—breast cancer	1.66e-05	0.000213	CcSEcCtD
Trabectedin—Dermatitis—Irinotecan—breast cancer	1.66e-05	0.000213	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Docetaxel—breast cancer	1.66e-05	0.000213	CcSEcCtD
Trabectedin—Headache—Mitoxantrone—breast cancer	1.65e-05	0.000212	CcSEcCtD
Trabectedin—Headache—Irinotecan—breast cancer	1.65e-05	0.000212	CcSEcCtD
Trabectedin—Hypotension—Capecitabine—breast cancer	1.65e-05	0.000211	CcSEcCtD
Trabectedin—Insomnia—Docetaxel—breast cancer	1.65e-05	0.000211	CcSEcCtD
Trabectedin—Paraesthesia—Docetaxel—breast cancer	1.64e-05	0.00021	CcSEcCtD
Trabectedin—Alopecia—Methotrexate—breast cancer	1.64e-05	0.00021	CcSEcCtD
Trabectedin—Vomiting—Gemcitabine—breast cancer	1.64e-05	0.000209	CcSEcCtD
Trabectedin—Dyspnoea—Docetaxel—breast cancer	1.63e-05	0.000208	CcSEcCtD
Trabectedin—Mental disorder—Methotrexate—breast cancer	1.62e-05	0.000208	CcSEcCtD
Trabectedin—Rash—Gemcitabine—breast cancer	1.62e-05	0.000208	CcSEcCtD
Trabectedin—Dermatitis—Gemcitabine—breast cancer	1.62e-05	0.000207	CcSEcCtD
Trabectedin—Malnutrition—Methotrexate—breast cancer	1.61e-05	0.000206	CcSEcCtD
Trabectedin—Haemoglobin—Doxorubicin—breast cancer	1.61e-05	0.000206	CcSEcCtD
Trabectedin—Headache—Gemcitabine—breast cancer	1.61e-05	0.000206	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Capecitabine—breast cancer	1.61e-05	0.000206	CcSEcCtD
Trabectedin—Flushing—Epirubicin—breast cancer	1.61e-05	0.000206	CcSEcCtD
Trabectedin—Vomiting—Fluorouracil—breast cancer	1.61e-05	0.000206	CcSEcCtD
Trabectedin—Dyspepsia—Docetaxel—breast cancer	1.61e-05	0.000206	CcSEcCtD
Trabectedin—Haemorrhage—Doxorubicin—breast cancer	1.6e-05	0.000205	CcSEcCtD
Trabectedin—Insomnia—Capecitabine—breast cancer	1.6e-05	0.000205	CcSEcCtD
Trabectedin—Rash—Fluorouracil—breast cancer	1.59e-05	0.000204	CcSEcCtD
Trabectedin—Dermatitis—Fluorouracil—breast cancer	1.59e-05	0.000204	CcSEcCtD
Trabectedin—Paraesthesia—Capecitabine—breast cancer	1.59e-05	0.000203	CcSEcCtD
Trabectedin—Decreased appetite—Docetaxel—breast cancer	1.59e-05	0.000203	CcSEcCtD
Trabectedin—Hypersensitivity—Paclitaxel—breast cancer	1.59e-05	0.000203	CcSEcCtD
Trabectedin—Headache—Fluorouracil—breast cancer	1.58e-05	0.000203	CcSEcCtD
Trabectedin—Oedema peripheral—Doxorubicin—breast cancer	1.58e-05	0.000202	CcSEcCtD
Trabectedin—Dysgeusia—Methotrexate—breast cancer	1.58e-05	0.000202	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Docetaxel—breast cancer	1.58e-05	0.000202	CcSEcCtD
Trabectedin—Connective tissue disorder—Doxorubicin—breast cancer	1.58e-05	0.000202	CcSEcCtD
Trabectedin—Dyspnoea—Capecitabine—breast cancer	1.58e-05	0.000202	CcSEcCtD
Trabectedin—Fatigue—Docetaxel—breast cancer	1.57e-05	0.000202	CcSEcCtD
Trabectedin—Angiopathy—Epirubicin—breast cancer	1.57e-05	0.000201	CcSEcCtD
Trabectedin—Nausea—Mitoxantrone—breast cancer	1.57e-05	0.000201	CcSEcCtD
Trabectedin—Nausea—Irinotecan—breast cancer	1.57e-05	0.000201	CcSEcCtD
Trabectedin—Mediastinal disorder—Epirubicin—breast cancer	1.56e-05	0.0002	CcSEcCtD
Trabectedin—Constipation—Docetaxel—breast cancer	1.56e-05	0.0002	CcSEcCtD
Trabectedin—Back pain—Methotrexate—breast cancer	1.56e-05	0.0002	CcSEcCtD
Trabectedin—Dyspepsia—Capecitabine—breast cancer	1.56e-05	0.000199	CcSEcCtD
Trabectedin—Asthenia—Paclitaxel—breast cancer	1.55e-05	0.000198	CcSEcCtD
Trabectedin—Decreased appetite—Capecitabine—breast cancer	1.54e-05	0.000197	CcSEcCtD
Trabectedin—Alopecia—Epirubicin—breast cancer	1.53e-05	0.000196	CcSEcCtD
Trabectedin—Nausea—Gemcitabine—breast cancer	1.53e-05	0.000196	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Capecitabine—breast cancer	1.53e-05	0.000195	CcSEcCtD
Trabectedin—Fatigue—Capecitabine—breast cancer	1.52e-05	0.000195	CcSEcCtD
Trabectedin—Mental disorder—Epirubicin—breast cancer	1.52e-05	0.000194	CcSEcCtD
Trabectedin—Constipation—Capecitabine—breast cancer	1.51e-05	0.000194	CcSEcCtD
Trabectedin—Malnutrition—Epirubicin—breast cancer	1.51e-05	0.000193	CcSEcCtD
Trabectedin—Nausea—Fluorouracil—breast cancer	1.5e-05	0.000192	CcSEcCtD
Trabectedin—Gastrointestinal pain—Docetaxel—breast cancer	1.49e-05	0.000191	CcSEcCtD
Trabectedin—Anaemia—Methotrexate—breast cancer	1.49e-05	0.000191	CcSEcCtD
Trabectedin—Flushing—Doxorubicin—breast cancer	1.49e-05	0.000191	CcSEcCtD
Trabectedin—Dysgeusia—Epirubicin—breast cancer	1.48e-05	0.000189	CcSEcCtD
Trabectedin—Diarrhoea—Paclitaxel—breast cancer	1.47e-05	0.000189	CcSEcCtD
Trabectedin—Back pain—Epirubicin—breast cancer	1.46e-05	0.000187	CcSEcCtD
Trabectedin—Angiopathy—Doxorubicin—breast cancer	1.46e-05	0.000186	CcSEcCtD
Trabectedin—Gastrointestinal pain—Capecitabine—breast cancer	1.45e-05	0.000185	CcSEcCtD
Trabectedin—Mediastinal disorder—Doxorubicin—breast cancer	1.45e-05	0.000185	CcSEcCtD
Trabectedin—Body temperature increased—Docetaxel—breast cancer	1.44e-05	0.000185	CcSEcCtD
Trabectedin—Abdominal pain—Docetaxel—breast cancer	1.44e-05	0.000185	CcSEcCtD
Trabectedin—Leukopenia—Methotrexate—breast cancer	1.44e-05	0.000185	CcSEcCtD
Trabectedin—Dizziness—Paclitaxel—breast cancer	1.42e-05	0.000182	CcSEcCtD
Trabectedin—Alopecia—Doxorubicin—breast cancer	1.42e-05	0.000181	CcSEcCtD
Trabectedin—Cough—Methotrexate—breast cancer	1.41e-05	0.00018	CcSEcCtD
Trabectedin—Mental disorder—Doxorubicin—breast cancer	1.41e-05	0.00018	CcSEcCtD
Trabectedin—Body temperature increased—Capecitabine—breast cancer	1.4e-05	0.000179	CcSEcCtD
Trabectedin—Abdominal pain—Capecitabine—breast cancer	1.4e-05	0.000179	CcSEcCtD
Trabectedin—Malnutrition—Doxorubicin—breast cancer	1.4e-05	0.000179	CcSEcCtD
Trabectedin—Anaemia—Epirubicin—breast cancer	1.39e-05	0.000179	CcSEcCtD
Trabectedin—Arthralgia—Methotrexate—breast cancer	1.37e-05	0.000176	CcSEcCtD
Trabectedin—Myalgia—Methotrexate—breast cancer	1.37e-05	0.000176	CcSEcCtD
Trabectedin—Vomiting—Paclitaxel—breast cancer	1.37e-05	0.000175	CcSEcCtD
Trabectedin—Dysgeusia—Doxorubicin—breast cancer	1.37e-05	0.000175	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.36e-05	0.000175	CcSEcCtD
Trabectedin—Rash—Paclitaxel—breast cancer	1.36e-05	0.000174	CcSEcCtD
Trabectedin—Dermatitis—Paclitaxel—breast cancer	1.36e-05	0.000174	CcSEcCtD
Trabectedin—Syncope—Epirubicin—breast cancer	1.35e-05	0.000173	CcSEcCtD
Trabectedin—Leukopenia—Epirubicin—breast cancer	1.35e-05	0.000173	CcSEcCtD
Trabectedin—Back pain—Doxorubicin—breast cancer	1.35e-05	0.000173	CcSEcCtD
Trabectedin—Headache—Paclitaxel—breast cancer	1.35e-05	0.000173	CcSEcCtD
Trabectedin—Hypersensitivity—Docetaxel—breast cancer	1.35e-05	0.000172	CcSEcCtD
Trabectedin—Loss of consciousness—Epirubicin—breast cancer	1.33e-05	0.00017	CcSEcCtD
Trabectedin—Cough—Epirubicin—breast cancer	1.32e-05	0.000169	CcSEcCtD
Trabectedin—Asthenia—Docetaxel—breast cancer	1.31e-05	0.000168	CcSEcCtD
Trabectedin—Infection—Methotrexate—breast cancer	1.31e-05	0.000167	CcSEcCtD
Trabectedin—Hypersensitivity—Capecitabine—breast cancer	1.3e-05	0.000167	CcSEcCtD
Trabectedin—Nervous system disorder—Methotrexate—breast cancer	1.29e-05	0.000165	CcSEcCtD
Trabectedin—Anaemia—Doxorubicin—breast cancer	1.29e-05	0.000165	CcSEcCtD
Trabectedin—Thrombocytopenia—Methotrexate—breast cancer	1.29e-05	0.000165	CcSEcCtD
Trabectedin—Arthralgia—Epirubicin—breast cancer	1.28e-05	0.000164	CcSEcCtD
Trabectedin—Myalgia—Epirubicin—breast cancer	1.28e-05	0.000164	CcSEcCtD
Trabectedin—Nausea—Paclitaxel—breast cancer	1.28e-05	0.000164	CcSEcCtD
Trabectedin—Skin disorder—Methotrexate—breast cancer	1.28e-05	0.000164	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.28e-05	0.000163	CcSEcCtD
Trabectedin—Asthenia—Capecitabine—breast cancer	1.27e-05	0.000162	CcSEcCtD
Trabectedin—Anorexia—Methotrexate—breast cancer	1.25e-05	0.000161	CcSEcCtD
Trabectedin—Syncope—Doxorubicin—breast cancer	1.25e-05	0.00016	CcSEcCtD
Trabectedin—Leukopenia—Doxorubicin—breast cancer	1.25e-05	0.00016	CcSEcCtD
Trabectedin—Diarrhoea—Docetaxel—breast cancer	1.25e-05	0.00016	CcSEcCtD
Trabectedin—Oedema—Epirubicin—breast cancer	1.23e-05	0.000158	CcSEcCtD
Trabectedin—Hypotension—Methotrexate—breast cancer	1.23e-05	0.000157	CcSEcCtD
Trabectedin—Loss of consciousness—Doxorubicin—breast cancer	1.23e-05	0.000157	CcSEcCtD
Trabectedin—Infection—Epirubicin—breast cancer	1.22e-05	0.000157	CcSEcCtD
Trabectedin—Cough—Doxorubicin—breast cancer	1.22e-05	0.000156	CcSEcCtD
Trabectedin—Shock—Epirubicin—breast cancer	1.21e-05	0.000155	CcSEcCtD
Trabectedin—Diarrhoea—Capecitabine—breast cancer	1.21e-05	0.000155	CcSEcCtD
Trabectedin—Nervous system disorder—Epirubicin—breast cancer	1.21e-05	0.000155	CcSEcCtD
Trabectedin—Dizziness—Docetaxel—breast cancer	1.21e-05	0.000155	CcSEcCtD
Trabectedin—Thrombocytopenia—Epirubicin—breast cancer	1.21e-05	0.000154	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Methotrexate—breast cancer	1.2e-05	0.000153	CcSEcCtD
Trabectedin—Skin disorder—Epirubicin—breast cancer	1.2e-05	0.000153	CcSEcCtD
Trabectedin—Insomnia—Methotrexate—breast cancer	1.19e-05	0.000152	CcSEcCtD
Trabectedin—Arthralgia—Doxorubicin—breast cancer	1.19e-05	0.000152	CcSEcCtD
Trabectedin—Myalgia—Doxorubicin—breast cancer	1.19e-05	0.000152	CcSEcCtD
Trabectedin—Paraesthesia—Methotrexate—breast cancer	1.18e-05	0.000151	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.18e-05	0.000151	CcSEcCtD
Trabectedin—Anorexia—Epirubicin—breast cancer	1.17e-05	0.00015	CcSEcCtD
Trabectedin—Dyspnoea—Methotrexate—breast cancer	1.17e-05	0.00015	CcSEcCtD
Trabectedin—Dizziness—Capecitabine—breast cancer	1.17e-05	0.00015	CcSEcCtD
Trabectedin—Vomiting—Docetaxel—breast cancer	1.16e-05	0.000149	CcSEcCtD
Trabectedin—Dyspepsia—Methotrexate—breast cancer	1.16e-05	0.000148	CcSEcCtD
Trabectedin—Rash—Docetaxel—breast cancer	1.15e-05	0.000147	CcSEcCtD
Trabectedin—Hypotension—Epirubicin—breast cancer	1.15e-05	0.000147	CcSEcCtD
Trabectedin—Dermatitis—Docetaxel—breast cancer	1.15e-05	0.000147	CcSEcCtD
Trabectedin—Decreased appetite—Methotrexate—breast cancer	1.14e-05	0.000146	CcSEcCtD
Trabectedin—Headache—Docetaxel—breast cancer	1.14e-05	0.000146	CcSEcCtD
Trabectedin—Oedema—Doxorubicin—breast cancer	1.14e-05	0.000146	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Methotrexate—breast cancer	1.14e-05	0.000145	CcSEcCtD
Trabectedin—Fatigue—Methotrexate—breast cancer	1.13e-05	0.000145	CcSEcCtD
Trabectedin—Infection—Doxorubicin—breast cancer	1.13e-05	0.000145	CcSEcCtD
Trabectedin—Vomiting—Capecitabine—breast cancer	1.12e-05	0.000144	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Epirubicin—breast cancer	1.12e-05	0.000144	CcSEcCtD
Trabectedin—Shock—Doxorubicin—breast cancer	1.12e-05	0.000144	CcSEcCtD
Trabectedin—Nervous system disorder—Doxorubicin—breast cancer	1.12e-05	0.000143	CcSEcCtD
Trabectedin—Thrombocytopenia—Doxorubicin—breast cancer	1.12e-05	0.000143	CcSEcCtD
Trabectedin—Rash—Capecitabine—breast cancer	1.11e-05	0.000143	CcSEcCtD
Trabectedin—Insomnia—Epirubicin—breast cancer	1.11e-05	0.000143	CcSEcCtD
Trabectedin—Dermatitis—Capecitabine—breast cancer	1.11e-05	0.000143	CcSEcCtD
Trabectedin—Headache—Capecitabine—breast cancer	1.11e-05	0.000142	CcSEcCtD
Trabectedin—Skin disorder—Doxorubicin—breast cancer	1.11e-05	0.000142	CcSEcCtD
Trabectedin—Paraesthesia—Epirubicin—breast cancer	1.11e-05	0.000142	CcSEcCtD
Trabectedin—Dyspnoea—Epirubicin—breast cancer	1.1e-05	0.000141	CcSEcCtD
Trabectedin—Anorexia—Doxorubicin—breast cancer	1.09e-05	0.000139	CcSEcCtD
Trabectedin—Nausea—Docetaxel—breast cancer	1.08e-05	0.000139	CcSEcCtD
Trabectedin—Dyspepsia—Epirubicin—breast cancer	1.08e-05	0.000139	CcSEcCtD
Trabectedin—Gastrointestinal pain—Methotrexate—breast cancer	1.08e-05	0.000138	CcSEcCtD
Trabectedin—Decreased appetite—Epirubicin—breast cancer	1.07e-05	0.000137	CcSEcCtD
Trabectedin—Hypotension—Doxorubicin—breast cancer	1.06e-05	0.000136	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Epirubicin—breast cancer	1.06e-05	0.000136	CcSEcCtD
Trabectedin—Fatigue—Epirubicin—breast cancer	1.06e-05	0.000136	CcSEcCtD
Trabectedin—Constipation—Epirubicin—breast cancer	1.05e-05	0.000135	CcSEcCtD
Trabectedin—Nausea—Capecitabine—breast cancer	1.05e-05	0.000134	CcSEcCtD
Trabectedin—Abdominal pain—Methotrexate—breast cancer	1.04e-05	0.000133	CcSEcCtD
Trabectedin—Body temperature increased—Methotrexate—breast cancer	1.04e-05	0.000133	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.04e-05	0.000133	CcSEcCtD
Trabectedin—Insomnia—Doxorubicin—breast cancer	1.03e-05	0.000132	CcSEcCtD
Trabectedin—Paraesthesia—Doxorubicin—breast cancer	1.02e-05	0.000131	CcSEcCtD
Trabectedin—Dyspnoea—Doxorubicin—breast cancer	1.02e-05	0.00013	CcSEcCtD
Trabectedin—Gastrointestinal pain—Epirubicin—breast cancer	1.01e-05	0.000129	CcSEcCtD
Trabectedin—Dyspepsia—Doxorubicin—breast cancer	1e-05	0.000128	CcSEcCtD
Trabectedin—Decreased appetite—Doxorubicin—breast cancer	9.9e-06	0.000127	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Doxorubicin—breast cancer	9.84e-06	0.000126	CcSEcCtD
Trabectedin—Fatigue—Doxorubicin—breast cancer	9.82e-06	0.000126	CcSEcCtD
Trabectedin—Constipation—Doxorubicin—breast cancer	9.74e-06	0.000125	CcSEcCtD
Trabectedin—Abdominal pain—Epirubicin—breast cancer	9.73e-06	0.000125	CcSEcCtD
Trabectedin—Body temperature increased—Epirubicin—breast cancer	9.73e-06	0.000125	CcSEcCtD
Trabectedin—Hypersensitivity—Methotrexate—breast cancer	9.69e-06	0.000124	CcSEcCtD
Trabectedin—Asthenia—Methotrexate—breast cancer	9.44e-06	0.000121	CcSEcCtD
Trabectedin—Gastrointestinal pain—Doxorubicin—breast cancer	9.32e-06	0.000119	CcSEcCtD
Trabectedin—Hypersensitivity—Epirubicin—breast cancer	9.07e-06	0.000116	CcSEcCtD
Trabectedin—Abdominal pain—Doxorubicin—breast cancer	9.01e-06	0.000115	CcSEcCtD
Trabectedin—Body temperature increased—Doxorubicin—breast cancer	9.01e-06	0.000115	CcSEcCtD
Trabectedin—Diarrhoea—Methotrexate—breast cancer	9e-06	0.000115	CcSEcCtD
Trabectedin—Asthenia—Epirubicin—breast cancer	8.83e-06	0.000113	CcSEcCtD
Trabectedin—Dizziness—Methotrexate—breast cancer	8.7e-06	0.000111	CcSEcCtD
Trabectedin—Diarrhoea—Epirubicin—breast cancer	8.43e-06	0.000108	CcSEcCtD
Trabectedin—Hypersensitivity—Doxorubicin—breast cancer	8.39e-06	0.000107	CcSEcCtD
Trabectedin—Vomiting—Methotrexate—breast cancer	8.37e-06	0.000107	CcSEcCtD
Trabectedin—Rash—Methotrexate—breast cancer	8.3e-06	0.000106	CcSEcCtD
Trabectedin—Dermatitis—Methotrexate—breast cancer	8.29e-06	0.000106	CcSEcCtD
Trabectedin—Headache—Methotrexate—breast cancer	8.24e-06	0.000106	CcSEcCtD
Trabectedin—Asthenia—Doxorubicin—breast cancer	8.17e-06	0.000105	CcSEcCtD
Trabectedin—Dizziness—Epirubicin—breast cancer	8.14e-06	0.000104	CcSEcCtD
Trabectedin—Vomiting—Epirubicin—breast cancer	7.83e-06	0.0001	CcSEcCtD
Trabectedin—Nausea—Methotrexate—breast cancer	7.82e-06	0.0001	CcSEcCtD
Trabectedin—Diarrhoea—Doxorubicin—breast cancer	7.8e-06	9.98e-05	CcSEcCtD
Trabectedin—Rash—Epirubicin—breast cancer	7.76e-06	9.94e-05	CcSEcCtD
Trabectedin—Dermatitis—Epirubicin—breast cancer	7.76e-06	9.93e-05	CcSEcCtD
Trabectedin—Headache—Epirubicin—breast cancer	7.71e-06	9.88e-05	CcSEcCtD
Trabectedin—Dizziness—Doxorubicin—breast cancer	7.53e-06	9.65e-05	CcSEcCtD
Trabectedin—Nausea—Epirubicin—breast cancer	7.31e-06	9.36e-05	CcSEcCtD
Trabectedin—Vomiting—Doxorubicin—breast cancer	7.24e-06	9.27e-05	CcSEcCtD
Trabectedin—Rash—Doxorubicin—breast cancer	7.18e-06	9.2e-05	CcSEcCtD
Trabectedin—Dermatitis—Doxorubicin—breast cancer	7.18e-06	9.19e-05	CcSEcCtD
Trabectedin—Headache—Doxorubicin—breast cancer	7.14e-06	9.14e-05	CcSEcCtD
Trabectedin—Nausea—Doxorubicin—breast cancer	6.77e-06	8.66e-05	CcSEcCtD
Trabectedin—SRC—Signaling Pathways—FGFR1—breast cancer	1.29e-06	2.7e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—STK11—breast cancer	1.29e-06	2.69e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP19A1—breast cancer	1.29e-06	2.69e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HRAS—breast cancer	1.29e-06	2.69e-05	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—AKT1—breast cancer	1.29e-06	2.69e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP3A4—breast cancer	1.28e-06	2.68e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.28e-06	2.67e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HIF1A—breast cancer	1.27e-06	2.66e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP3A4—breast cancer	1.27e-06	2.66e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.26e-06	2.64e-05	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—AKT1—breast cancer	1.26e-06	2.64e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MDM2—breast cancer	1.26e-06	2.64e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP1B1—breast cancer	1.26e-06	2.64e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—RAF1—breast cancer	1.26e-06	2.63e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—MTHFR—breast cancer	1.25e-06	2.62e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP1B1—breast cancer	1.25e-06	2.61e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1B—breast cancer	1.25e-06	2.61e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—ERBB2—breast cancer	1.24e-06	2.6e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—LEP—breast cancer	1.24e-06	2.6e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CD—breast cancer	1.24e-06	2.59e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HRAS—breast cancer	1.24e-06	2.59e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—HSP90AA1—breast cancer	1.24e-06	2.59e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—IL6—breast cancer	1.23e-06	2.58e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CAV1—breast cancer	1.23e-06	2.58e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MTOR—breast cancer	1.23e-06	2.57e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CB—breast cancer	1.23e-06	2.57e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL1B—breast cancer	1.23e-06	2.56e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CD4—breast cancer	1.22e-06	2.56e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—HSP90AA1—breast cancer	1.22e-06	2.56e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—ALB—breast cancer	1.22e-06	2.56e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL2—breast cancer	1.22e-06	2.55e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KDR—breast cancer	1.22e-06	2.55e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PTGS2—breast cancer	1.22e-06	2.54e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.21e-06	2.53e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NCOA1—breast cancer	1.2e-06	2.51e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—COMT—breast cancer	1.2e-06	2.51e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTP1—breast cancer	1.19e-06	2.49e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NCOA1—breast cancer	1.19e-06	2.49e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—JUN—breast cancer	1.19e-06	2.49e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ESR1—breast cancer	1.19e-06	2.48e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—STK11—breast cancer	1.18e-06	2.48e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP19A1—breast cancer	1.18e-06	2.48e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CTNNB1—breast cancer	1.18e-06	2.47e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—HMOX1—breast cancer	1.18e-06	2.46e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP19A1—breast cancer	1.17e-06	2.46e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—STK11—breast cancer	1.17e-06	2.46e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ITPR1—breast cancer	1.17e-06	2.45e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—FN1—breast cancer	1.17e-06	2.45e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—NOS3—breast cancer	1.17e-06	2.45e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—MED12—breast cancer	1.17e-06	2.45e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—DPYD—breast cancer	1.17e-06	2.45e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NFKBIA—breast cancer	1.16e-06	2.42e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CAV1—breast cancer	1.16e-06	2.42e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1B—breast cancer	1.15e-06	2.41e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—CDKN1A—breast cancer	1.15e-06	2.41e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALDOA—breast cancer	1.15e-06	2.41e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PTEN—breast cancer	1.15e-06	2.4e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOTCH1—breast cancer	1.15e-06	2.4e-05	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—AKT1—breast cancer	1.14e-06	2.38e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ABCB1—breast cancer	1.13e-06	2.36e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MAPK8—breast cancer	1.12e-06	2.35e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—APC—breast cancer	1.12e-06	2.35e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CG—breast cancer	1.12e-06	2.35e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KIT—breast cancer	1.12e-06	2.35e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NCOA3—breast cancer	1.12e-06	2.34e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC2A2—breast cancer	1.11e-06	2.32e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGF—breast cancer	1.11e-06	2.32e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—TYMS—breast cancer	1.11e-06	2.32e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.1e-06	2.31e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—COMT—breast cancer	1.1e-06	2.3e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTP1—breast cancer	1.1e-06	2.29e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.09e-06	2.29e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GSTM1—breast cancer	1.09e-06	2.29e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NCOR1—breast cancer	1.09e-06	2.29e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—COMT—breast cancer	1.09e-06	2.28e-05	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—AKT1—breast cancer	1.09e-06	2.28e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CTNNB1—breast cancer	1.09e-06	2.28e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—MTR—breast cancer	1.09e-06	2.27e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CPT1A—breast cancer	1.09e-06	2.27e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ABCG2—breast cancer	1.09e-06	2.27e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTP1—breast cancer	1.09e-06	2.27e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—HMOX1—breast cancer	1.08e-06	2.26e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CB—breast cancer	1.08e-06	2.26e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ITPR1—breast cancer	1.08e-06	2.26e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—HMOX1—breast cancer	1.07e-06	2.24e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTGS2—breast cancer	1.07e-06	2.24e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ITPR1—breast cancer	1.07e-06	2.24e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HPGDS—breast cancer	1.07e-06	2.23e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—CDKN1A—breast cancer	1.06e-06	2.22e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PTEN—breast cancer	1.06e-06	2.22e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HBA1—breast cancer	1.06e-06	2.22e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—BRAF—breast cancer	1.05e-06	2.21e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CG—breast cancer	1.05e-06	2.21e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—GPX1—breast cancer	1.05e-06	2.19e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP1A1—breast cancer	1.04e-06	2.17e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ABCB1—breast cancer	1.04e-06	2.17e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTT1—breast cancer	1.03e-06	2.16e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ACHE—breast cancer	1.03e-06	2.16e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ERCC2—breast cancer	1.03e-06	2.15e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ABCB1—breast cancer	1.03e-06	2.15e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—STAT3—breast cancer	1.03e-06	2.15e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IGF1—breast cancer	1.03e-06	2.15e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT2—breast cancer	1.03e-06	2.15e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—TYMS—breast cancer	1.02e-06	2.13e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—TYMS—breast cancer	1.01e-06	2.11e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.01e-06	2.11e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GSTM1—breast cancer	1.01e-06	2.11e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NCOR1—breast cancer	1.01e-06	2.11e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GSTM1—breast cancer	9.98e-07	2.09e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PLA2G4A—breast cancer	9.98e-07	2.09e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NCOR1—breast cancer	9.98e-07	2.09e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CD—breast cancer	9.86e-07	2.06e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—MAPK3—breast cancer	9.81e-07	2.05e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP17A1—breast cancer	9.79e-07	2.05e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SERPINE1—breast cancer	9.75e-07	2.04e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS1—breast cancer	9.69e-07	2.03e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ENO1—breast cancer	9.69e-07	2.03e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—MTHFR—breast cancer	9.68e-07	2.03e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—GPX1—breast cancer	9.64e-07	2.02e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—GPX1—breast cancer	9.56e-07	2e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP1A1—breast cancer	9.55e-07	2e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP2D6—breast cancer	9.5e-07	1.99e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—STAT3—breast cancer	9.48e-07	1.98e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ERCC2—breast cancer	9.47e-07	1.98e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP1A1—breast cancer	9.46e-07	1.98e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ERCC2—breast cancer	9.39e-07	1.96e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PTEN—breast cancer	9.34e-07	1.95e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—EGFR—breast cancer	9.34e-07	1.95e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NCOA2—breast cancer	9.32e-07	1.95e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NOS3—breast cancer	9.31e-07	1.95e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CD—breast cancer	9.26e-07	1.94e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—ALB—breast cancer	9.15e-07	1.91e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MAPK3—breast cancer	9.06e-07	1.9e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—FASN—breast cancer	9.04e-07	1.89e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—BCHE—breast cancer	9.01e-07	1.88e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CAV1—breast cancer	8.93e-07	1.87e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—MTHFR—breast cancer	8.9e-07	1.86e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC5A5—breast cancer	8.9e-07	1.86e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MDM2—breast cancer	8.83e-07	1.85e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—MTHFR—breast cancer	8.82e-07	1.85e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—KRAS—breast cancer	8.82e-07	1.85e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—MYC—breast cancer	8.81e-07	1.84e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RAF1—breast cancer	8.8e-07	1.84e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—TGFB1—breast cancer	8.79e-07	1.84e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—RELA—breast cancer	8.76e-07	1.83e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—NOS3—breast cancer	8.75e-07	1.83e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—ERBB2—breast cancer	8.71e-07	1.82e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—EGFR—breast cancer	8.62e-07	1.8e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CB—breast cancer	8.59e-07	1.8e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MTOR—breast cancer	8.59e-07	1.8e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—SLC2A1—breast cancer	8.59e-07	1.8e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NQO1—breast cancer	8.59e-07	1.8e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	8.53e-07	1.78e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL8—breast cancer	8.26e-07	1.73e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP1B1—breast cancer	8.24e-07	1.72e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CAV1—breast cancer	8.21e-07	1.72e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—KRAS—breast cancer	8.14e-07	1.7e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CAV1—breast cancer	8.14e-07	1.7e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CG—breast cancer	8.13e-07	1.7e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—PIK3CA—breast cancer	8.1e-07	1.7e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HSP90AA1—breast cancer	8.08e-07	1.69e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CB—breast cancer	8.07e-07	1.69e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1B—breast cancer	8.07e-07	1.69e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTGS2—breast cancer	8e-07	1.67e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CASP3—breast cancer	7.9e-07	1.65e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL2—breast cancer	7.89e-07	1.65e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NCOA1—breast cancer	7.86e-07	1.64e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.78e-07	1.63e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP19A1—breast cancer	7.74e-07	1.62e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—STK11—breast cancer	7.74e-07	1.62e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCND1—breast cancer	7.69e-07	1.61e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—JUN—breast cancer	7.68e-07	1.61e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CTNNB1—breast cancer	7.62e-07	1.59e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—HRAS—breast cancer	7.5e-07	1.57e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—PIK3CA—breast cancer	7.48e-07	1.57e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CG—breast cancer	7.48e-07	1.56e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MMP9—breast cancer	7.47e-07	1.56e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CDKN1A—breast cancer	7.44e-07	1.56e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PTEN—breast cancer	7.43e-07	1.55e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CG—breast cancer	7.41e-07	1.55e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAPK8—breast cancer	7.26e-07	1.52e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—COMT—breast cancer	7.2e-07	1.51e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL6—breast cancer	7.18e-07	1.5e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTP1—breast cancer	7.17e-07	1.5e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CD—breast cancer	7.15e-07	1.5e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—HMOX1—breast cancer	7.07e-07	1.48e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—ALB—breast cancer	7.06e-07	1.48e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ITPR1—breast cancer	7.05e-07	1.48e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PTEN—breast cancer	6.98e-07	1.46e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—HRAS—breast cancer	6.92e-07	1.45e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ABCB1—breast cancer	6.78e-07	1.42e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NOS3—breast cancer	6.75e-07	1.41e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFA—breast cancer	6.71e-07	1.4e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—TYMS—breast cancer	6.66e-07	1.39e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—STAT3—breast cancer	6.64e-07	1.39e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—IL6—breast cancer	6.62e-07	1.39e-05	CbGpPWpGaD
Trabectedin—SRC—Immune System—AKT1—breast cancer	6.62e-07	1.39e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PIK3CA—breast cancer	6.59e-07	1.38e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GSTM1—breast cancer	6.58e-07	1.38e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PLA2G4A—breast cancer	6.58e-07	1.38e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NCOR1—breast cancer	6.58e-07	1.38e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CD—breast cancer	6.57e-07	1.38e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CD—breast cancer	6.52e-07	1.36e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—ALB—breast cancer	6.49e-07	1.36e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—ALB—breast cancer	6.43e-07	1.35e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MAPK3—breast cancer	6.35e-07	1.33e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—GPX1—breast cancer	6.31e-07	1.32e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP1A1—breast cancer	6.24e-07	1.31e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CB—breast cancer	6.23e-07	1.3e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NOS3—breast cancer	6.21e-07	1.3e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ERCC2—breast cancer	6.19e-07	1.3e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTGS2—breast cancer	6.17e-07	1.29e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—MYC—breast cancer	6.17e-07	1.29e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TGFB1—breast cancer	6.16e-07	1.29e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NOS3—breast cancer	6.15e-07	1.29e-05	CbGpPWpGaD
Trabectedin—SRC—Disease—AKT1—breast cancer	6.11e-07	1.28e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—EGFR—breast cancer	6.04e-07	1.26e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—MTHFR—breast cancer	5.82e-07	1.22e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CB—breast cancer	5.73e-07	1.2e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—KRAS—breast cancer	5.7e-07	1.19e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CB—breast cancer	5.68e-07	1.19e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTGS2—breast cancer	5.68e-07	1.19e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTGS2—breast cancer	5.63e-07	1.18e-05	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PTEN—breast cancer	5.38e-07	1.13e-05	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—AKT1—breast cancer	5.38e-07	1.13e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CAV1—breast cancer	5.37e-07	1.12e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—PIK3CA—breast cancer	5.24e-07	1.1e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—breast cancer	5.07e-07	1.06e-05	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PTEN—breast cancer	4.95e-07	1.04e-05	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PIK3CA—breast cancer	4.92e-07	1.03e-05	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PTEN—breast cancer	4.91e-07	1.03e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CG—breast cancer	4.89e-07	1.02e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HRAS—breast cancer	4.85e-07	1.01e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL6—breast cancer	4.64e-07	9.71e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CD—breast cancer	4.3e-07	8.99e-06	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—AKT1—breast cancer	4.28e-07	8.96e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—ALB—breast cancer	4.24e-07	8.88e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NOS3—breast cancer	4.06e-07	8.49e-06	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—AKT1—breast cancer	4.02e-07	8.42e-06	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PIK3CA—breast cancer	3.8e-07	7.95e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CB—breast cancer	3.75e-07	7.84e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTGS2—breast cancer	3.71e-07	7.77e-06	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PIK3CA—breast cancer	3.49e-07	7.31e-06	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PIK3CA—breast cancer	3.46e-07	7.25e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PTEN—breast cancer	3.24e-07	6.77e-06	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—AKT1—breast cancer	3.1e-07	6.49e-06	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—AKT1—breast cancer	2.85e-07	5.97e-06	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—AKT1—breast cancer	2.83e-07	5.92e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PIK3CA—breast cancer	2.28e-07	4.78e-06	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—AKT1—breast cancer	1.87e-07	3.9e-06	CbGpPWpGaD
